HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay.

AbstractBACKGROUND:
Drug-resistance and therapy failure due to drug-drug interactions are the main challenges in current treatment against Human Immunodeficiency Virus (HIV) infection. As such, there is a continuous need for the development of new and more potent anti-HIV drugs. Here we established a high-throughput screen based on the highly permissive TZM-bl cell line to identify novel HIV inhibitors. The assay allows discriminating compounds acting on early and/or late steps of the HIV replication cycle.
RESULTS:
The platform was used to screen a unique library of secondary metabolites derived from myxobacteria. Several hits with good anti-HIV profiles were identified. Five of the initial hits were tested for their antiviral potency. Four myxobacterial compounds, sulfangolid C, soraphen F, epothilon D and spirangien B, showed EC50 values in the nM range with SI > 15. Interestingly, we found a high amount of overlapping hits compared with a previous screen for Hepatitis C Virus (HCV) using the same library.
CONCLUSION:
The unique structures and mode-of-actions of these natural compounds make myxobacteria an attractive source of chemicals for the development of broad-spectrum antivirals. Further biological and structural studies of our initial hits might help recognize smaller drug-like derivatives that in turn could be synthesized and further optimized.
AuthorsJavier P Martinez, Bettina Hinkelmann, Eric Fleta-Soriano, Heinrich Steinmetz, Rolf Jansen, Juana Diez, Ronald Frank, Florenz Sasse, Andreas Meyerhans
JournalMicrobial cell factories (Microb Cell Fact) Vol. 12 Pg. 85 (Sep 24 2013) ISSN: 1475-2859 [Electronic] England
PMID24063434 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-HIV Agents
Topics
  • Anti-HIV Agents (isolation & purification, pharmacology)
  • Drug Resistance
  • High-Throughput Screening Assays (methods)
  • Humans
  • Myxococcales (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: